Xenon製藥 XENE 深 滬
等待開盤 03-26 09:30:00 美东时间
55.57
+2.190
+4.10%
華盛通- 最 高56.29
- 今 開53.905
- 成交量 183.38万股
- 最 低 53.905
- 昨 收 53.38
- 總市值 53.03亿
- 52周最高 63.95
- 市盈率 靜 --
- 換手率 1.92%
- 52周最低 26.74
- 委 比 31.79%
- 總股本 9542.72万
- 歷史最高 63.95
- 量 比 1.21
- 振 幅 4.47%
- 歷史最低 2.10
- 每 手 1
- 風險率 6.21%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Revolution, Ascendis, Arrowhead among RBC’s top M&A candidates in biotech
RBC Capital Markets has compiled a list of 13 biotechs that are most likely to receive takeover interest, including Revolution Medicines (RVMD), Ascendis Pharma (ASND), and Arrowhead Pharma (ARWR), am...
03-20 02:37
美股大行评级 | 能源股获大行青睐！美国铝业、康索尔能源、康菲石油、EOG能源等获上调目标价；多只航空股遭下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Altimmune"买入"评级，目标价从12美元升至25美元；BTIG：维持Jade Biosciences"买入"评级，目标价从28美元升至39美元
03-17 11:45
Wedbush Maintains Outperform on Xenon Pharmaceuticals, Lowers Price Target to $63
Wedbush analyst Laura Chico maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform and lowers the price target from $64 to $63.
03-16 20:29
美股周涨跌榜 | 与诺和诺德“世纪大和解”！Hims周内暴涨超57%；PayPay上市两日涨超32%
与诺和诺德“世纪大和解”！Hims周内暴涨超57%；近十年日企赴美最大IPO，PayPay上市两日涨超32%；获英伟达20亿美元投资，Nebius周涨超26%>>
03-14 10:29
美股大行评级 | 潜在涨幅467.73%！Corbus制药控股获Oppenheimer升目标价至57美元，维持"跑赢大市"评级
今日重点评级关注：Oppenheimer：维持Corbus制药控股"跑赢大市"评级，目标价从53美元升至57美元；Canaccord Genuity：维持WAVE Life Sciences"买入"评级，目标价从43美元升至52美元
03-11 12:40
Xenon Raises $650 Million in Upsized U.S. Equity Offering
An update from Xenon ( ($XENE) ) is now available. Xenon Pharmaceuticals has pr...
03-11 11:08
美股牛股 | 医药股齐升！Xenon制药飙升近50%，癫痫新药临床试验获重大突破；HIMS大涨40%
医药股齐升！Xenon制药飙升近50%，癫痫新药临床试验获重大突破；HIMS大涨40%，获诺和诺德授权销售其减肥药；QURE大涨26%，FDA疫苗负责人将离职，有分析称监管政策或转向灵活>>
03-10 16:46
美股大行评级 | 潜在涨幅148%！瑞银、小摩等8家大行首予SOLV Energy买入评级目标价42美元；甲骨文绩前遭德银等下调目标价；京东遭巴克莱下调目标价
今日重点评级关注：Evercore ISI集团：维持Caribou Biosciences"跑赢大市"评级，目标价从11美元升至13美元；富国银行：上调uniQure评级至"超配"，目标价从15美元升至60美元
03-10 15:05
Xenon Pharmaceuticals Commences $500M Common Stock Offering
Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today
03-10 04:01
What's Going On With Biohaven Stock On Monday?
Biohaven shares rose in premarket trading after Xenon's Phase 3 epilepsy study showed strong seizure reduction results.
03-09 23:47
